MKI67 and metastatic neoplasm: However, immunohistochemical analysis of the proliferation marker Ki67 showed that ICAM-1−/− mice that developed hepatic metastatic tumors proportionally contained the same levels of Ki67 when compared with metastatic tumors from WT mice (Figure 2b).